REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 21st, 2018 • Cancer Genetics, Inc • Services-medical laboratories • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of this 18th day of September, 2018, by and among Cancer Genetics, Inc., a Delaware corporation (the “Company”), and NovellusDX, Ltd., a company established under the laws of the State of Israel (“NDX”). Capitalized terms used herein have the respective meanings ascribed thereto in that certain Credit Agreement, dated as of the date hereof, by and between the Company and NDX (the “Credit Agreement”), unless otherwise defined herein.
ContractCancer Genetics, Inc • September 21st, 2018 • Services-medical laboratories • Delaware
THIS NOTE AND THE INDEBTEDNESS EVIDENCED HEREBY ARE SUBORDINATE IN THE MANNER AND TO THE EXTENT SET FORTH IN THAT CERTAIN SUBORDINATION AGREEMENT (THE “SVB SUBORDINATION AGREEMENT”) DATED AS OF THE DATE HEREOF BY AND AMONG LENDER, BORROWER, SILICON VALLEY BANK AND THE OTHER PARTIES THERETO TO THE SENIOR DEBT (AS DEFINED IN THE SVB SUBORDINATION AGREEMENT). THIS NOTE AND THE INDEBTEDNESS EVIDENCED HEREBY ARE ALSO SUBORDINATE IN THE MANNER AND TO THE EXTENT SET FORTH IN THAT CERTAIN SUBORDINATION AGREEMENT (THE “PFG SUBORDINATION AGREEMENT,” AND TOGETHER WITH THE SVB SUBORDINATION AGREEMENT, THE “SUBORDINATION AGREEMENTS”) DATED AS OF THE DATE HEREOF BY AND AMONG LENDER, BORROWER, PARTNERS FOR GROWTH IV, L.P. AND THE OTHER PARTIES THERETO TO THE SENIOR DEBT (AS DEFINED IN THE PFG SUBORDINATION AGREEMENT); AND THE HOLDER OF THIS NOTE, BY ITS ACCEPTANCE HEREOF, SHALL BE BOUND BY THE PROVISIONS OF THE SUBORDINATION AGREEMENTS.
